...
首页> 外文期刊>Journal of Immunological Methods >Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
【24h】

Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.

机译:抗口蹄疫病毒非结构蛋白3ABC重组抗体的生产和应用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The stamping out of animals to control a foot-and-mouth disease (FMD) outbreak results in enormous livestock losses. The implementation of vaccination strategies can reduce these losses; however it complicates the process of establishing freedom from disease following an outbreak. The availability of quality diagnostic tests to differentiate infected from vaccinated animals (DIVA) is crucial to prove freedom from disease and allow for the resumption of trade in livestock products. All current foot-and-mouth disease virus (FMDV) DIVA tests rely on polyclonal or monoclonal hybridoma derived antibody reagents, which can be difficult to prepare and maintain in a quality-assured manner and in the quantities required for post-outbreak surveillance. Recombinant antibodies can be produced in large quantities at low cost in bacteria to guarantee the supply of a consistent and well-characterised reagent. The production of recombinant antibodies does not rely on animal immunisation and does not require the maintenance of viable hybridoma cell lines. In this study, phage display libraries of recombinant antibody single chain variable fragments (scFv) against FMDV were generated from chickens immunised with recombinant non-structural protein (NSP) 3ABC. A total of 32 positive clones were obtained that represented three distinctive genetic sequences, Chicken Recombinant Antibody-Foot-and-Mouth disease (CRAb-FM) 26, -FM27 and -FM29. Each was shown to bind the 3B region of the 3ABC protein. When evaluated in a C-ELISA format using sera derived from cattle, sheep and pigs representing naive, FMDV-vaccinated or FMDV-infected animals, CRAb-FM27 gave the best performance when paired with an E. coli-derived recombinant 3ABC, demonstrating the potential to be used as a species- and serotype-independent FMDV DIVA test. To our knowledge, this is the first FMDV DIVA test that uses both recombinant antibody and antigen derived from bacterial expression systems.
机译:淘汰动物以控制口蹄疫(FMD)爆发会导致大量牲畜损失。实施疫苗接种策略可以减少这些损失;但是,这会使爆发后建立免受疾病侵害的过程变得复杂。提供高质量的诊断测试以区分感染的动物和疫苗的动物(DIVA)对于证明没有疾病并允许恢复畜产品贸易至关重要。当前所有的口蹄疫病毒(FMDV)DIVA测试都依赖于多克隆或单克隆杂交瘤衍生的抗体试剂,这些试剂可能很难以质量保证的方式进行制备和维护,且难以维持暴发后监测所需的数量。重组抗体可以在细菌中以低成本大量生产,以确保提供一致且特性良好的试剂。重组抗体的产生不依赖于动物免疫,并且不需要维持活的杂交瘤细胞系。在这项研究中,针对重组FMDV的重组抗体单链可变片段(scFv)的噬菌体展示文库是从用重组非结构蛋白(NSP)3ABC免疫的鸡中产生的。总共获得了代表三个独特遗传序列的32个阳性克隆,即鸡重组抗体-口蹄疫(CRAb-FM)26,-FM27和-FM29。显示每个都结合3ABC蛋白的3B区。当使用代表原始,经FMDV疫苗接种或FMDV感染的动物的牛,绵羊和猪的血清以C-ELISA格式评估时,与大肠杆菌来源的重组3ABC配对时,CRAb-FM27的性能最佳。有潜力用作与物种和血清型无关的FMDV DIVA测试。据我们所知,这是首次使用重组抗体和源自细菌表达系统的抗原的FMDV DIVA测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号